SI3303320T1 - Nove heterociklične spojine, postopek za pripravo le-teh in farmacevtski sestavek vsebujoč le-te - Google Patents

Nove heterociklične spojine, postopek za pripravo le-teh in farmacevtski sestavek vsebujoč le-te

Info

Publication number
SI3303320T1
SI3303320T1 SI201630590T SI201630590T SI3303320T1 SI 3303320 T1 SI3303320 T1 SI 3303320T1 SI 201630590 T SI201630590 T SI 201630590T SI 201630590 T SI201630590 T SI 201630590T SI 3303320 T1 SI3303320 T1 SI 3303320T1
Authority
SI
Slovenia
Prior art keywords
same
preparing
pharmaceutical composition
heterocyclic compound
novel heterocyclic
Prior art date
Application number
SI201630590T
Other languages
English (en)
Inventor
Joon Seok Park
Youn Jung Yoon
Min Jae Cho
Ho Bin Lee
Ja Kyung Yoo
Bong Yong Lee
Original Assignee
Daewoong Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Pharmaceutical Co., Ltd. filed Critical Daewoong Pharmaceutical Co., Ltd.
Publication of SI3303320T1 publication Critical patent/SI3303320T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SI201630590T 2015-06-08 2016-06-07 Nove heterociklične spojine, postopek za pripravo le-teh in farmacevtski sestavek vsebujoč le-te SI3303320T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020150080722A KR102277538B1 (ko) 2015-06-08 2015-06-08 신규한 헤테로 고리 화합물, 이의 제조 방법 및 이를 포함하는 약학적 조성물
EP16807756.8A EP3303320B1 (en) 2015-06-08 2016-06-07 Novel heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same
PCT/KR2016/005999 WO2016200116A1 (en) 2015-06-08 2016-06-07 Novel heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same

Publications (1)

Publication Number Publication Date
SI3303320T1 true SI3303320T1 (sl) 2020-02-28

Family

ID=57504227

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201630590T SI3303320T1 (sl) 2015-06-08 2016-06-07 Nove heterociklične spojine, postopek za pripravo le-teh in farmacevtski sestavek vsebujoč le-te

Country Status (21)

Country Link
US (1) US10011586B2 (sl)
EP (1) EP3303320B1 (sl)
JP (1) JP6605624B2 (sl)
KR (1) KR102277538B1 (sl)
CN (1) CN107428725B (sl)
AU (1) AU2016275210B2 (sl)
BR (1) BR112017020053B1 (sl)
CA (1) CA2977752C (sl)
ES (1) ES2769279T3 (sl)
HR (1) HRP20200104T8 (sl)
HU (1) HUE047537T2 (sl)
MA (1) MA42455B1 (sl)
MY (1) MY172656A (sl)
NZ (1) NZ735032A (sl)
PH (1) PH12017501735A1 (sl)
PL (1) PL3303320T3 (sl)
PT (1) PT3303320T (sl)
RS (1) RS59787B1 (sl)
RU (1) RU2675375C1 (sl)
SI (1) SI3303320T1 (sl)
WO (1) WO2016200116A1 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2795368T3 (es) 2014-06-23 2020-11-23 Dae Woong Pharma Compuesto heterocíclico novedoso
AR110963A1 (es) * 2017-02-07 2019-05-22 Dae Woong Pharma Compuestos heterocíclicos, su método de preparación y composición farmacéutica que los comprende
KR20230092805A (ko) * 2021-12-17 2023-06-26 주식회사 대웅제약 (2R, 3S)-2-(3-(4,5-디클로로-1H-벤조[d]이미다졸-1-일)프로필)피페리딘-3-올의 신규한 산부가염 및 결정형
WO2024080777A1 (ko) * 2022-10-12 2024-04-18 주식회사 대웅제약 신장염의 예방 또는 치료용 약학적 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0709384T3 (da) * 1994-10-31 1999-08-23 Merck Patent Gmbh Benzylpiperidinderivater med høj affinitet til aminosyrereceptorers bindingssteder
AU2009282480B2 (en) 2008-08-11 2015-05-07 Children's Medical Center Corporation Halofuginone analogs for inhibition of tRNA synthetases and uses thereof
WO2010096170A2 (en) * 2009-02-19 2010-08-26 President And Fellows Of Harvard College Inhibition of trna synthetases and therapeutic applications thereof
JP2015506363A (ja) 2012-01-13 2015-03-02 プレジデント アンド フェローズ オブ ハーバード カレッジ ハロフジノール誘導体、および化粧料組成物および医薬組成物におけるその使用
CA2899363A1 (en) * 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
KR20160065986A (ko) * 2013-10-24 2016-06-09 조지타운 유니버시티 암 치료용 방법 및 조성물
ES2795368T3 (es) * 2014-06-23 2020-11-23 Dae Woong Pharma Compuesto heterocíclico novedoso

Also Published As

Publication number Publication date
PL3303320T3 (pl) 2020-06-29
RS59787B1 (sr) 2020-02-28
HRP20200104T1 (hr) 2020-04-03
EP3303320A1 (en) 2018-04-11
BR112017020053B1 (pt) 2023-01-31
JP2018515558A (ja) 2018-06-14
US20180044322A1 (en) 2018-02-15
KR20160144213A (ko) 2016-12-16
PH12017501735A1 (en) 2018-03-12
NZ735032A (en) 2019-05-31
EP3303320B1 (en) 2020-01-01
CA2977752A1 (en) 2016-12-15
MY172656A (en) 2019-12-09
MA42455B1 (fr) 2020-02-28
CN107428725A (zh) 2017-12-01
EP3303320A4 (en) 2018-12-05
JP6605624B2 (ja) 2019-11-13
HRP20200104T8 (hr) 2021-02-19
HUE047537T2 (hu) 2020-05-28
KR102277538B1 (ko) 2021-07-14
CN107428725B (zh) 2020-01-03
AU2016275210B2 (en) 2018-07-26
CA2977752C (en) 2020-03-31
AU2016275210A1 (en) 2017-09-21
PT3303320T (pt) 2020-02-03
WO2016200116A1 (en) 2016-12-15
US10011586B2 (en) 2018-07-03
RU2675375C1 (ru) 2018-12-19
ES2769279T3 (es) 2020-06-25
BR112017020053A2 (pt) 2018-06-05

Similar Documents

Publication Publication Date Title
ZA201708663B (en) Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same
HK1243999A1 (zh) 新型3-吲哚取代的衍生物、藥物組合物及使用方法
PT3580208T (pt) Derivados de 2-(3-(1h-benzo[d]imidazol-1-il)propil)piperidin-3-ol e compostos relacionados como inibidores de prs para tratamento de, por exemplo, cancro
EP3351242A4 (en) ORAL PHARMACEUTICAL COMPOSITION COMPRISING CANNABINOID, PROCESS FOR PREPARATION AND USE THEREOF
IL253538A0 (en) Heterocyclic compound and pharmaceutical compound containing it
EP3115361A4 (en) Heterocyclic compounds, and preparation method and use thereof
HRP20200104T8 (hr) Novi heterociklični spoj, metoda za pripremu istog, i farmaceutska kompozicija koja sadrži isto
ZA201805600B (en) Pyrimidine seven-membered-ring compounds, preparation method therefor, pharmaceutical composition thereof, and uses thereof
IL251456A0 (en) Substances with agonist activity for gpr119, processes for their preparation and preparations containing them
EP3284743A4 (en) Heterocyclic-imidazole compounds, pharmaceutical compositions thereof, preparation method therefor and use thereof
ZA201908090B (en) Pharmaceutical composition and method for preparing same
HUE060710T2 (hu) Aprepitantot tartalmazó gyógyszerkészítmény és eljárás annak elõállítására
EP3305283A4 (en) STABILIZED PHARMACEUTICAL COMPOSITION AND PROCESS FOR PREPARING THE SAME
HRP20190193T1 (hr) Novi derivati fosfanina i azofosfanina,postupak njihove priprave te farmaceutski pripravci koji ih sadrže
EP3138830A4 (en) Composition containing 3-chloro-4-methoxybenzylamine hydrochloride, and method for producing same